(Q34140718)

31 July 2017

1 reference

title

The renin angiotensin system as a risk factor for coronary artery disease (English)

1 reference

31 July 2017

0 references

coronary artery disease

1 reference

Farmer JA

1

1 reference

PubMed ID

11177655

31 July 2017

Torre-Amione G

series ordinal

2

1 reference

31 July 2017

1 March 2001

1 reference

Current Atherosclerosis Reports

31 July 2017

1 reference

31 July 2017

3

1 reference

31 July 2017

117-124

1 reference

31 July 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-001-0047-2

31 July 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0047-2

Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-001-0047-2

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-001-0047-2

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-001-0047-2

Effects of valsartan and 17 beta-estradiol on the oxidation of low-density lipoprotein in vitro

21 January 2018

1 reference

12 December 2020

The role of tumor necrosis factor alpha in the pathophysiology of congestive heart failure

1 reference

12 December 2020

The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

1 reference

12 December 2020

Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men

1 reference

12 December 2020

Hypertensive left ventricular remodeling and ACE-gene polymorphism

1 reference

12 December 2020

Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: a review of clinical investigations

1 reference

12 December 2020

Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition

1 reference

12 December 2020

Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms

1 reference

12 December 2020

Angiotensin induces inflammatory activation of human vascular smooth muscle cells

1 reference

12 December 2020

ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension

1 reference

12 December 2020

Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia

1 reference

12 December 2020

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

1 reference

12 December 2020

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction

1 reference

12 December 2020

Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients

1 reference

12 December 2020

The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity

1 reference

12 December 2020

The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia

1 reference

12 December 2020

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

12 December 2020

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

12 December 2020

The multiple actions of angiotensin II in atherosclerosis

1 reference

12 December 2020

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

12 December 2020

Angiotensin-II type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failure

1 reference

12 December 2020

Angiotensin AT1 receptor over-expression in hypercholesterolaemia

1 reference

12 December 2020

Angiotensin-converting enzyme and cardiovascular disease risk

1 reference

12 December 2020

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

12 December 2020

Angiotensin II, adhesion, and cardiac fibrosis

1 reference

12 December 2020

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension

1 reference

12 December 2020

Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators

1 reference

12 December 2020

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

12 December 2020

10.1007/S11883-001-0047-2

Identifiers

DOI

1 reference

PubMed ID

11177655

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11177655